<DOC>
	<DOC>NCT01079819</DOC>
	<brief_summary>The purpose of the study is to evaluate the pharmacokinetics, safety and tolerability of BMS-708163 administered as single and multiple doses in Chinese subjects</brief_summary>
	<brief_title>Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-708163</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Healthy male subjects 1845 yrs old and 65 yrs or older inclusive and postmenopausal female 65 yrs or older Women of childbearing potential Gastrointestinal disorders Bleeding disorders Peptic ulcer disease Abnormal ECG Abnormal Clinical laboratory tests Abnormal Thyroid Congestive heart failure Cholecystectomy Asthma Hypertension Inability to tolerate oral medication Inability to be venipunctured and/or tolerate venous access</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>